
Altamira Therapeutics Investor Relations Material
Latest events

H2 2024
Altamira Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Altamira Therapeutics Ltd
Access all reports
Altamira Therapeutics Ltd is a Switzerland-based biopharmaceutical company focused on developing and commercializing therapies for ear, nose, and throat (ENT) and central nervous system (CNS) disorders. The company's pipeline includes RNA-based therapeutics, as well as treatments for inner ear conditions such as tinnitus and vertigo. Altamira Therapeutics applies its proprietary delivery platforms to target therapeutic molecules effectively, aiming to address unmet medical needs across its key treatment areas. The company is headquartered in Hamilton, Bermuda, and its shares are listed on the NASDAQ.
Key slides for Altamira Therapeutics Ltd


Corporate Presentation
Altamira Therapeutics Ltd


Corporate Presentation
Altamira Therapeutics Ltd
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
CYTO
Country
🇺🇸 United States